|
What's Happening
Wednesday
Article Update
Feb. 26, 2025
|
|
|
Since January has passed and we are well into February, it’s time to discontinue RSV vaccination during pregnancy. The recommendation to discontinue RSV vaccination for individuals 32 through 36 weeks pregnant is Jan. 31 of each year, which aligns with the RSV season. RSV vaccination of pregnant women 32 through 36 weeks gestation should resume on Sept. 1.
As RSV continues circulating, the Centers for Disease Control and Prevention (CDC) recommends continuing to immunize infants younger than 8 months of age with Nirsevimab (Beyfortus) through March 31. The RSV preventive antibodies in Nirsevimab provides immediate protection. High-risk infants ages 8 months through 19 months should also get Nirsevimab during their second RSV season.
For additional vaccination guidance see the Child and Adolescent Immunization Schedule by Age | Vaccines & Immunizations | CDC.
|
|
|
|
